Literature DB >> 32609814

Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate.

Kathryn Lurain1, Thomas S Uldrick1, Ramya Ramaswami1, Mark N Polizzotto1, Priscila H Goncalves1, Anaida Widell1, Seth M Steinberg2, Elaine S Jaffe3, Stefania Pittaluga3, Hao-Wei Wang3, Constance M Yuan3, Mary Anne Tamula4, Staci Martin5, Pamela L Wolters5, Jomy George6, Richard F Little1, Robert Yarchoan1.   

Abstract

Entities:  

Year:  2020        PMID： 32609814      PMCID： PMC7645985          DOI： 10.1182/blood.2020006048

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Authors:  Lauren E Abrey; Tracy T Batchelor; Andrés J M Ferreri; Mary Gospodarowicz; Elisa J Pulczynski; Emanuele Zucca; Justine R Smith; Agnieszka Korfel; Carole Soussain; Lisa M DeAngelis; Edward A Neuwelt; Brian Patrick O'Neill; Eckhard Thiel; Tamara Shenkier; Fransesc Graus; Martin van den Bent; John F Seymour; Philip Poortmans; James O Armitage; Franco Cavalli
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

3.  Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma.

Authors:  B R Donahue; J W Sullivan; J S Cooper
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

4.  Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix M Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

7.  Survival among patients with primary central nervous system lymphoma, 1973-2004.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

8.  Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.

Authors:  Teri N Kreisl; Katherine S Panageas; Elena B Elkin; Lisa M Deangelis; Lauren E Abrey
Journal:  Leuk Lymphoma       Date:  2008-09

9.  Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.

Authors:  Emmanuelle Boulanger; Marie-Thérèse Daniel; Félix Agbalika; Eric Oksenhendler
Journal:  Am J Hematol       Date:  2003-07       Impact factor: 10.047

10.  Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Authors:  James L Rubenstein; Eric D Hsi; Jeffrey L Johnson; Sin-Ho Jung; Megan O Nakashima; Barbara Grant; Bruce D Cheson; Lawrence D Kaplan
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544
View more
  6 in total

1.  Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settings.

Authors:  Sagun Parakh; Hui K Gan
Journal:  Neurooncol Pract       Date:  2022-04-03

Review 2.  HIV/AIDS Associated Lymphoma: Review.

Authors:  Ayenew Berhan; Biruk Bayleyegn; Zegeye Getaneh
Journal:  Blood Lymphat Cancer       Date:  2022-04-29

3.  EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

Authors:  M K Gandhi; T Hoang; S C Law; S Brosda; K O'Rourke; J W D Tobin; F Vari; V Murigneux; L Fink; J Gunawardana; C Gould; H Oey; K Bednarska; S Delecluse; R U Trappe; L Merida de Long; M B Sabdia; G Bhagat; G Hapgood; E Blyth; L Clancy; J Wight; E Hawkes; L M Rimsza; A Maguire; K Bojarczuk; B Chapuy; C Keane
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

4.  Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.

Authors:  Kathryn Lurain; Ramya Ramaswami; Ralph Mangusan; Anaida Widell; Irene Ekwede; Jomy George; Richard Ambinder; Martin Cheever; James L Gulley; Priscila H Goncalves; Hao-Wei Wang; Thomas S Uldrick; Robert Yarchoan
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

Review 5.  HIV-Associated Lymphomas: Progress and New Challenges.

Authors:  Georgios N Pongas; Juan C Ramos
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

6.  A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus.

Authors:  Christopher Dittus; Natalie Grover; Tarsheen Sethi; Jonathon B Cohen; Alfredo Voloschin; Janhvi Rabadey; Xianming Tan; Anne Beaven; Steven I Park
Journal:  EJHaem       Date:  2022-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.